Free Trial
NASDAQ:TNDM

Tandem Diabetes Care Q2 2025 Earnings Report

Tandem Diabetes Care logo
$15.40 -0.18 (-1.16%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$15.69 +0.29 (+1.88%)
As of 08/1/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Tandem Diabetes Care EPS Results

Actual EPS
N/A
Consensus EPS
-$0.40
Beat/Miss
N/A
One Year Ago EPS
N/A

Tandem Diabetes Care Revenue Results

Actual Revenue
N/A
Expected Revenue
$238.39 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Tandem Diabetes Care Announcement Details

Quarter
Q2 2025
Time
After Market Closes
Conference Call Date
Wednesday, August 6, 2025
Conference Call Time
4:30PM ET

Conference Call Resources

Tandem Diabetes Care Earnings Headlines

Your blueprint for crypto wealth
Mark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…
See More Tandem Diabetes Care Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Tandem Diabetes Care? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tandem Diabetes Care and other key companies, straight to your email.

About Tandem Diabetes Care

Tandem Diabetes Care (NASDAQ:TNDM), a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

View Tandem Diabetes Care Profile

More Earnings Resources from MarketBeat